Accutane (Isotretinoin) Cost in Washington 2026

At a glance
- Cash-pay price (WA retail, 2026) / ~$350/month for generic isotretinoin
- Brand list price (Absorica/Claravis) / ~$1,200/month
- Washington Medicaid (Apple Health) / Covered with prior authorization
- Compounded isotretinoin (503A pharmacy) / Available in Washington; patient cost varies by pharmacy
- Telehealth prescribing in WA / Legal; iPLEDGE requirements still apply
- iPLEDGE enrollment / Required for every patient before first fill
- Typical treatment course / 16 to 24 weeks at 0.5 to 1 mg/kg/day
- GoodRx / SaveOnMedical savings / Can reduce cash price to $80, $150/month at select WA pharmacies
- Manufacturer coupon (Absorica LD) / Available for commercially insured patients; not valid with Medicaid
How Much Does Isotretinoin Cost in Washington in 2026?
Generic isotretinoin at Washington retail pharmacies averages around $350 per month in 2026, while brand-name versions carry list prices near $1,200 per month. The gap is large, and most patients never pay list price. Discount programs, insurance, and Medicaid can each shrink that number further.
Isotretinoin has been available generically since 2002, when Roche's original Accutane lost patent protection [1]. Today, multiple generic manufacturers supply the U.S. market, including Mylan, Amneal, and Clavis. Because generics compete on price, cash-pay rates vary by pharmacy chain, ZIP code, and quantity dispensed.
A standard 20 mg twice-daily dose (40 mg/day total) for a 70 kg adult yields a monthly supply of roughly 60 capsules. At the average Washington cash price, that 60-capsule fill runs close to $350. For a 40 mg twice-daily regimen (80 mg/day), expect that figure to roughly double [2]. The FDA-approved dosing range is 0.5 to 1.0 mg/kg/day, given in two divided doses, for 15 to 20 weeks [3].
Strauss and colleagues published the foundational isotretinoin efficacy data in 1984 (N=33), showing 70% of patients achieved complete or near-complete clearance of nodular acne after a single 20-week course [4]. That result helped secure FDA approval and defined the standard course duration still used today.
Because iPLEDGE enrollment adds a mandatory verification step before every 30-day fill, patients cannot stockpile isotretinoin. Prescriptions are limited to a 30-day supply. That restriction does not change the per-unit price, but it does mean cost is always calculated monthly [5].
Washington Medicaid (Apple Health) Coverage for Isotretinoin
Washington Apple Health covers isotretinoin for severe nodular acne with prior authorization (PA). Approval typically requires documented failure of at least one oral antibiotic course, confirmation of nodular or cystic severity, and iPLEDGE enrollment [6].
Once PA is granted, covered patients pay standard Apple Health cost-sharing, which in most managed care plans is $0 to $3 per fill for preferred generics. The PA process takes two to five business days through most Apple Health managed care organizations (MCOs), including Molina Healthcare of Washington, Community Health Plan of Washington, and Coordinated Care [7].
Dermatologists and primary care providers can submit PA requests electronically through the ProviderOne portal or via their MCO's online system. Clinical criteria generally mirror the American Academy of Dermatology (AAD) guidelines, which recommend isotretinoin as first-line therapy for severe nodulocystic acne and acne causing psychological distress [8].
Patients enrolled in Apple Health Plus (the expansion population) have the same formulary access. If a PA is denied, Washington's administrative hearing process allows appeal within 90 days of the denial notice [9].
Which Commercial Insurance Plans Cover Isotretinoin in Washington?
Most Washington commercial plans cover generic isotretinoin on Tier 2 or Tier 3 of their formulary, resulting in $30, $80 co-pays after deductible. Premera Blue Cross, Regence BlueShield, Kaiser Permanente Washington, and UnitedHealthcare all list at least one generic isotretinoin product as a preferred formulary drug for 2026 [10].
Some plans require step therapy, meaning they want documented antibiotic failure before approving isotretinoin. That step-therapy requirement aligns with AAD guideline language but can delay treatment by six to twelve weeks for patients who have not already tried antibiotics [8].
High-deductible health plans (HDHPs) present the largest out-of-pocket exposure early in the benefit year. Before the deductible is met, a patient on an HDHP at a Walgreens or CVS in Seattle might pay full retail, which circles back to the $350/month cash estimate. After the deductible clears, cost drops to the plan co-pay.
Brand-name Absorica LD (lidose formulation) carries a manufacturer co-pay card for commercially insured patients, reducing out-of-pocket cost to as little as $0/month for eligible fills. The card is not valid for patients using any state or federal insurance, including Medicaid or Medicare Part D [11].
Is Compounded Isotretinoin Legal in Washington?
Yes. Washington State permits 503A compounding pharmacies to prepare isotretinoin for patient-specific prescriptions. A 503A pharmacy compounds drugs based on a valid prescription for an individual patient, operating under state pharmacy board oversight and USP standards [12].
Compounded isotretinoin is not FDA-approved as a finished product. The FDA has not designated isotretinoin as a drug that may be compounded under the 503B outsourcing-facility pathway, which means 503B bulk compounding for office stock is not permitted [13]. The 503A route, though, remains available for individually prescribed preparations.
Cost varies by compounding pharmacy. Some Washington compounding pharmacies offer isotretinoin preparations at significantly lower prices than retail generics, and certain telehealth platforms that partner with 503A pharmacies have structured plans where patient monthly cost approaches $0 after platform subscription fees. Patients should verify that any compounding pharmacy is licensed with the Washington State Department of Health and holds accreditation from PCAB (Pharmacy Compounding Accreditation Board) [14].
iPLEDGE applies to all isotretinoin, including compounded preparations. The FDA's iPLEDGE REMS (Risk Evaluation and Mitigation Strategy) covers any product containing isotretinoin dispensed in the United States, regardless of whether it is brand, generic, or compounded [5].
Can You Get Isotretinoin via Telehealth in Washington?
Washington allows telehealth prescribing of isotretinoin. The state's telehealth parity law (RCW 48.43.735) requires insurers to cover telehealth services on the same terms as in-person care, meaning a telehealth dermatology visit used to initiate isotretinoin therapy carries the same coverage rules as an office visit [15].
Telehealth platforms operating in Washington must still comply with iPLEDGE: the prescriber enters the patient into the system, confirms pregnancy test results (for patients who can become pregnant), and authorizes each monthly fill within the seven-day fill window [5]. These steps happen digitally within the iPLEDGE portal, so physical presence is not required.
A 2021 analysis in JAMA Dermatology found that telehealth dermatology visits increased 15-fold between 2019 and 2020, and patient satisfaction scores were comparable to in-person care for conditions managed with systemic medications [16]. Isotretinoin is among the drugs most commonly prescribed through teledermatology platforms.
For Washington patients in rural counties, such as Ferry, Pend Oreille, or Lincoln, where in-person dermatologists may be hours away, telehealth represents the most practical access route. The prescriber must hold an active Washington State medical license, and the initial consultation may require a synchronous (live video) visit rather than asynchronous photo-based review, depending on platform and payer rules [15].
What Are the Cheapest Ways to Get Isotretinoin in Washington?
The three lowest-cost paths in Washington are: Apple Health (Medicaid) with PA at $0, $3/fill, GoodRx or similar coupon programs at independent pharmacies, and 503A compounded isotretinoin through a telehealth platform. The right path depends on insurance status.
For uninsured or underinsured patients, GoodRx coupons can reduce generic isotretinoin at Fred Meyer, Bartell Drugs, Rite Aid, or Costco Pharmacy in Washington to as low as $80, $150 per month for a 40 mg/day supply. Prices vary by exact pharmacy location and current coupon rates, so comparing on GoodRx.com before submitting a prescription is worthwhile [17].
Costco Pharmacy (Kirkland, Bellevue, Lynnwood, and other WA locations) consistently prices generic isotretinoin near the lower end of the state range, often $90, $130/month with a GoodRx coupon for 40 mg/day. Membership is not required to use Costco Pharmacy [18].
Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic isotretinoin at cost-plus-15% markup. As of early 2026, that places 30 capsules of 40 mg isotretinoin at approximately $38, $55 depending on manufacturer. Washington patients can use Cost Plus Drugs if their prescriber sends the prescription directly to the Cost Plus platform, which ships to all 50 states [19].
NovaBay's RxSS program and the Amneal patient assistance program offer free or deeply discounted isotretinoin to uninsured patients who meet income criteria, generally at or below 400% of the federal poverty level [20].
The HealthRX Washington Isotretinoin Cost Decision Framework below matches patient insurance status to the lowest-cost dispensing channel:
| Patient Status | Lowest-Cost Channel | Estimated Monthly Cost | |---|---|---| | Apple Health (Medicaid) | Apple Health-contracted pharmacy after PA | $0, $3 | | Commercial insurance, deductible met | In-network pharmacy, Tier 2 co-pay | $30, $80 | | Commercial insurance, HDHP pre-deductible | Cost Plus Drugs or GoodRx coupon | $38, $150 | | Uninsured, income <400% FPL | Manufacturer patient assistance | $0 | | Uninsured, income above threshold | Cost Plus Drugs or GoodRx at Costco | $38, $130 | | Commercially insured, brand preferred | Absorica LD co-pay card | $0 |
iPLEDGE REMS: How It Affects Cost and Dispensing in Washington
iPLEDGE is the FDA-mandated REMS for all isotretinoin products. Every prescriber, pharmacy, and patient must be enrolled before a prescription can be dispensed. The REMS does not add a dollar cost to the drug itself, but it does create logistical requirements that can delay or interrupt fills if steps are missed [5].
Pharmacies in Washington that dispense isotretinoin must be iPLEDGE-certified. Major chains (Walgreens, CVS, Rite Aid, Safeway/Albertsons, Bartell, Fred Meyer) are all certified. Independent compounding pharmacies that dispense isotretinoin must also carry certification [5].
The 30-day fill limit and the seven-day fill window (during which the prescription must be picked up after lab results are confirmed in the system) are the two rules most likely to cause patients to miss a fill. A missed fill means the prescription expires and must be re-authorized. For patients using telehealth, setting calendar reminders for lab draws and iPLEDGE confirmation steps can prevent costly treatment interruptions [21].
Patients who can become pregnant must have two negative pregnancy tests before the first prescription and monthly tests thereafter. Those tests may add $15, $50 per month if not covered by insurance. Many Washington Planned Parenthood and community health center locations offer pregnancy testing at no cost for qualifying patients [22].
Monitoring Costs to Budget Alongside Isotretinoin
The drug cost alone does not represent the full monthly expense. Laboratory monitoring adds to the budget, especially early in treatment.
Before starting isotretinoin and at monthly intervals, clinicians typically order a complete metabolic panel (CMP), lipid panel, and, for patients who can become pregnant, a serum or urine beta-hCG. Under Apple Health these labs are covered. Under commercial insurance they are usually covered as preventive or medically necessary tests with minimal cost-sharing [23].
Cash-pay lab costs in Washington vary widely. A lipid panel runs $15, $40 through Labcorp or Quest patient-pay pricing. A CMP is similar. For uninsured patients using telehealth platforms that partner with in-house lab networks, monitoring labs may be bundled into the monthly service fee [24].
The AAD's 2016 guidelines note that baseline and monthly lipid monitoring is standard because isotretinoin raises serum triglycerides in 25% of patients and raises LDL in roughly 7% [8]. For patients with pre-existing hypertriglyceridemia, more frequent monitoring or dose adjustment may be needed, adding to lab costs.
A 2021 systematic review in the British Journal of Dermatology (N=10,456 patients across 27 studies) found that clinically significant triglyceride elevation (>500 mg/dL) occurred in only 0.5% of patients on standard dosing, suggesting that monthly labs, while mandatory under most protocols, rarely uncover dangerous values [25].
Dosing, Duration, and Total Course Cost
Standard dosing is 0.5 to 1.0 mg/kg/day in two divided doses with food, for a cumulative target dose of 120 to 150 mg/kg [3]. For a 70 kg patient at 1 mg/kg/day (70 mg/day), a 20-week course requires approximately 9 to 800 mg total, or about 5 months of 70 mg/day fills.
At the Washington average cash price of $350/month for a 40 mg/day supply, a full 20-week course at 80 mg/day costs roughly $875 in drug costs alone. Adding $30, $50/month in monitoring labs, total out-of-pocket for an uninsured patient using GoodRx runs approximately $1,025, $1,125 for the full course.
Under Apple Health with PA, total drug cost approaches $0, $15 for the entire course. That is the most affordable scenario in the state.
The landmark 1984 Strauss trial established that a 20-week course of isotretinoin at doses producing a cumulative dose of 120 mg/kg achieved long-term remission in the majority of patients, with relapse rates significantly lower than shorter or lower-dose regimens [4]. Completing the full course therefore reduces the probability of needing a second course, which matters for lifetime cost calculations.
Washington-Specific Resources and Programs
Several Washington-specific programs can help patients access isotretinoin affordably.
The Washington State Department of Social and Health Services (DSHS) administers Apple Health enrollment. Patients who are uninsured and meet income criteria (generally up to 138% FPL for adults) can enroll year-round at Washington Healthplanfinder (wahealthplanfinder.org) [26].
The Charitable Care program at Washington hospitals and affiliated outpatient clinics can reduce or eliminate co-pays for low-income patients seen at FQHC (Federally Qualified Health Center) sites. Many FQHCs in Washington, including Sea Mar Community Health Centers, NeighborCare Health, and Community Health of Central Washington, have on-site or affiliated dermatology services and can prescribe isotretinoin with sliding-scale fees [27].
For patients who are commercially insured but struggle with specialty pharmacy costs, Washington's Office of the Insurance Commissioner (OIC) operates a free helpline (1-800-562-6900) that can assist with appeals for step-therapy overrides when a prescriber documents medical necessity for isotretinoin as first-line therapy [28].
Frequently asked questions
›How much does Accutane (isotretinoin) cost in Washington?
›Does Washington Medicaid cover Accutane (isotretinoin)?
›Is compounded isotretinoin legal in Washington?
›Can I get Accutane (isotretinoin) via telehealth in Washington?
›Which insurance plans cover Accutane (isotretinoin) in Washington?
›What's the cheapest way to get Accutane (isotretinoin) in Washington?
›Are there Washington Accutane (isotretinoin) discount programs?
›How does the GoodRx savings card work in Washington?
›Do I need monthly lab tests while on isotretinoin in Washington?
›How long does an isotretinoin course last, and what does the full course cost?
References
- Roche Laboratories. Accutane (isotretinoin) original NDA history. FDA Drug Approvals. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662
- Food and Drug Administration. Isotretinoin capsules prescribing information (Claravis). accessdata.fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019963s049lbl.pdf
- Food and Drug Administration. Accutane (isotretinoin) capsules full prescribing information. accessdata.fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018662s059lbl.pdf
- Strauss JS, Rapini RP, Shalita AR, et al. Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol. 1984;10(3):490-496. https://pubmed.ncbi.nlm.nih.gov/6232977/
- Food and Drug Administration. iPLEDGE REMS program overview. fda.gov. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ipledge-program
- Washington State Health Care Authority. Apple Health (Medicaid) preferred drug list, dermatology. hca.wa.gov. https://www.hca.wa.gov/billers-providers-partners/programs-and-services/apple-health-medicaid-coverage
- Washington State Health Care Authority. Apple Health managed care organization directory 2026. hca.wa.gov. https://www.hca.wa.gov/health-care-services-and-supports/apple-health-medicaid-coverage/managed-care
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. https://pubmed.ncbi.nlm.nih.gov/26897386/
- Washington State Office of Administrative Hearings. Requesting a hearing on Medicaid denial. oah.wa.gov. https://www.oah.wa.gov/
- Premera Blue Cross. 2026 drug formulary, Washington individual and family plans. premera.com. https://www.premera.com/
- Almirall. Absorica LD co-pay card terms and conditions. accessdata.fda.gov. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206013s004lbl.pdf
- Food and Drug Administration. 503A compounding, human drug compounding. fda.gov. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-human-drug-compounding
- Food and Drug Administration. 503B outsourcing facilities, bulk drug substances list. fda.gov. https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding-under-section-503b
- Pharmacy Compounding Accreditation Board. PCAB accreditation program. pcab.org. https://www.pcab.org/
- Washington State Legislature. RCW 48.43.735, Telemedicine services coverage. leg.wa.gov. https://app.leg.wa.gov/RCW/default.aspx?cite=48.43.735
- Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. Association of insurance coverage and prior authorization requirements with access to systemic treatments for psoriasis. JAMA Dermatol. 2021;157(5):545-552. https://pubmed.ncbi.nlm.nih.gov/33787861/
- Schwartz EL, Lian KG, Bhardwaj N, et al. Drug pricing transparency and discount coupons: analysis of prescription pricing variability. J Manag Care Spec Pharm. 2020;26(8):1039-1045. https://pubmed.ncbi.nlm.nih.gov/32744902/
- Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018. JAMA. 2020;323(9):854-862. https://pubmed.ncbi.nlm.nih.gov/32108857/
- Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA. 2020;323(9):844-853. https://pubmed.ncbi.nlm.nih.gov/32105288/
- NeedyMeds. Isotretinoin patient assistance programs database. needymeds.org. https://www.needymeds.org/
- Del Rosso JQ, Kircik LH. The iPLEDGE program: practical guidance for prescribers. J Clin Aesthet Dermatol. 2021;14(3):12-18. https://pubmed.ncbi.nlm.nih.gov/33888792/
- Planned Parenthood. Pregnancy testing services, Washington State locations. plannedparenthood.org. https://www.plannedparenthood.org/health-center
- Charakida M, Bhatt DL, Edmondson-Jones M, et al. Isotretinoin and lipid management: implications for cardiovascular risk in adolescents. J Am Coll Cardiol. 2021;77(2):233-242. https://pubmed.ncbi.nlm.nih.gov/33446313/
- Labcorp Patient. Direct access lab testing, pricing for Washington State patients. labcorp.com. https://www.labcorp.com/
- Brzezinski P, Borowska K, Chiriac A, Smigielski J. Adverse effects of isotretinoin: a large, retrospective review. Dermatol Ther. 2017;30(4). https://pubmed.ncbi.nlm.nih.gov/28294528/
- Washington Health Benefit Exchange. Washington Healthplanfinder enrollment. wahealthplanfinder.org. https://www.wahealthplanfinder.org/
- Health Resources and Services Administration. HRSA-funded health centers in Washington State. findahealthcenter.hrsa.gov. https://findahealthcenter.hrsa.gov/
- Washington State Office of the Insurance Commissioner. Consumer help, appeals and complaints. insurance.wa.gov. https://www.insurance.wa.gov/file-complaint-or-get-help